Unjha Formulations (BOM:531762) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531762 Unjha Formulations Ltd BOM:531762
73 GF Score
Price ₹23.81
GF Value ₹23.14
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Unjha Formulations Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Unjha Formulations's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:531762 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Unjha Formulations's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unjha Formulations Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Unjha Formulations's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Unjha Formulations's Margin of Safety % (DCF Earnings Based) falls into.


BOM:531762
73GF Score
Unjha Formulations Ltd BOM:531762
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Unjha Formulations (BOM:531762) Overvalued in 2026?

Based on GuruFocus' analysis, Unjha Formulations stock appears to be overvalued. The current stock price of ₹23.81 is trading 2.9% above its estimated GF Value™ of ₹23.14. GuruFocus considers Unjha Formulations to be Fairly Valued.

Key valuation signals for BOM:531762:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹23.14 vs. price of ₹23.81 (2.9% above fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the BOM:531762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unjha Formulations Business Description

Address Khali Char Rasta, State Highway, Sidhpur, Khali, Patan, GJ, IND, 384151
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.
73GF Score

Get the complete analysis for BOM:531762

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.81
Price
₹23.14
GF Value